REGENERON PHARMACEUTICALS, INC. (REGN)
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
BILL HOLDINGS, INC. (BILL)
BILL Names Jonathan Leaf as Chief Revenue Officer to Accelerate Growth and Elevate Customer Experience
MARVELL TECHNOLOGY, INC. (MRVL)
Marvell Technology, Inc. Declares Quarterly Dividend Payment
PETVIVO HOLDINGS INC. (PETV)
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
KEROS THERAPEUTICS, INC. (KROS)
Keros Therapeutics Appoints Anne Prener to its Board of Directors
NRX PHARMACEUTICALS, INC. (NRXP)
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
TRUIST FINANCIAL CORP (TFC)
Truist announces release of 2026 CCAR results
MCGRATH RENTCORP (MGRC)
McGrath Second Quarter Earnings and Conference Call Scheduled for July 29, 2026
WISE GROUP PLC (WSE)
Wise Group plc reports Full Year 2026 Financial Results
TAYSHA GENE THERAPIES, INC. (TSHA)
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting